These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11685903)

  • 1. Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
    Uusimaa P; Tokola H; Ruskoaho H; Vuolteenaho O; Risteli J; Ylitalo A; Peuhkurinen K;
    J Hum Hypertens; 2001 Aug; 15 Suppl 1():S19-22. PubMed ID: 11685903
    [No Abstract]   [Full Text] [Related]  

  • 2. Natriuretic peptides and collagen biomarkers in patients with medical treatment for hypertension.
    Uusimaa P; Peuhkurinen S; Ylitalo A; Vuolteenaho O; Risteli J; Peuhkurinen K;
    Acta Cardiol; 2011 Feb; 66(1):21-7. PubMed ID: 21446378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive therapy: campaign of the giants].
    Füessl HS
    MMW Fortschr Med; 2005 Dec; 147(51-52):28. PubMed ID: 16402700
    [No Abstract]   [Full Text] [Related]  

  • 4. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
    Poulter NR; Dobson JE; Sever PS; Dahlöf B; Wedel H; Campbell NR;
    J Am Coll Cardiol; 2009 Sep; 54(13):1154-61. PubMed ID: 19761936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treating essential hypertension. Are beta blockers still first choice?].
    Rahn KH
    MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
    Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perindopril arginine + amlodipine for the treatment of hypertension in the USA.
    Elliott WJ
    Expert Opin Pharmacother; 2015; 16(14):2217-29. PubMed ID: 26325023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension with perindopril reduces plasma atrial natriuretic peptide levels, left ventricular mass, and improves echocardiographic parameters of diastolic function.
    Yalçin F; Aksoy FG; Muderrisoglu H; Sabah I; Garcia MJ; Thomas JD
    Clin Cardiol; 2000 Jun; 23(6):437-41. PubMed ID: 10875035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertension--does it matter how blood pressure is lowered?].
    Mehlsen J
    Ugeskr Laeger; 2008 Sep; 170(36):2782-4. PubMed ID: 18761872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new dimension in hypertension management with the amlodipine/perindopril combination.
    Poulter NR
    J Hypertens; 2011 Dec; 29 Suppl 1():S15-21. PubMed ID: 22157563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.
    Gupta AK; Poulter NR; Dobson J; Eldridge S; Cappuccio FP; Caulfield M; Collier D; Cruickshank JK; Sever PS; Feder G;
    Am J Hypertens; 2010 Sep; 23(9):1023-30. PubMed ID: 20725056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk.
    Gupta AK; Nasothimiou EG; Chang CL; Sever PS; Dahlöf B; Poulter NR;
    J Hypertens; 2011 Oct; 29(10):2004-13. PubMed ID: 21881528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.
    Olsen MH; Wachtell K; Tuxen C; Fossum E; Bang LE; Hall C; Ibsen H; Rokkedal J; Devereux RB; Hildebrandt PR
    J Hypertens; 2005 May; 23(5):1083-90. PubMed ID: 15834296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
    Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
    Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.
    Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
    J Hum Hypertens; 2001 Aug; 15 Suppl 1():S11-2. PubMed ID: 11685901
    [No Abstract]   [Full Text] [Related]  

  • 17. A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.
    Antonios TF; Cappuccio FP; Markandu ND; Sagnella GA; MacGregor GA
    Hypertension; 1996 Jun; 27(6):1325-8. PubMed ID: 8641743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
    Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASCOT blood pressure-lowering arm--study of effects of two BP-lowering regimens in hypertensive patients with cardiovascular risk factors.
    Cardiovasc J S Afr; 2005; 16(2):124, 126-7. PubMed ID: 15915281
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
    Ruilope LM; Schaefer A
    Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.